Tigatuzumab (CS-1008) is a Humanized Death Receptor 5 (DR5) IgG1 mAb
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily of cytokines, is a type 2 membrane protein expressed in the majority of normal tissues. TRAIL can undergo…